Exicure Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.24

+0.02 (+1.23%)

As of Sep 28, 10:32 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +2,395.5% upside

Low Target $21.30

Average Target $30.82

High Target $34.43

Current Price $1.24

Current
$1.24

Target
$30.82

$21.30 $30.82 avg $34.43

Scenario Analysis

Bear Case

$21.30

1,624.7%

Low target

Base Case

$30.82

+2,395.5%

Avg target

Bull Case

$34.43

+2,687.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$9.48

-87.0% from high

52-Week Low

$1.05

+17.6% from low

Target vs 52W High

$30.82

+225.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%